Human herpes virus 8-negative primary effusion lymphoma (PEL) in a patient after repeated chylous ascites and chylothorax

Internal Medicine

Volumn 43, Issue 3, 2004, Pages 236-242

  Nonami, Atsushi ^a,c   Yokoyama, Toshihiro ^a   Takeshita, Morishige ^a   Ohshima, Koichi ^b   Kubota, Akira ^a   Okamura, Seiichi ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Chylothorax; Chylous ascites; HHV 8 negative; HIV negative; Primary effusion lymphoma; Protein losing enteropathy

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DIURETIC AGENT; ETOPOSIDE; PIRARUBICIN; PREDNISONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BASOPHILIA; CASE REPORT; CELL VACUOLE; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; CHYLOTHORAX; CHYLOUS ASCITES; CYTOPLASM; DIPLOIDY; DOSE RESPONSE; FEMALE; HUMAN; HUMAN HERPESVIRUS 8; LABORATORY TEST; LYMPHOMA CELL; PARACENTESIS; PATHOGENESIS; PHYSICAL EXAMINATION; PRIMARY EFFUSION LYMPHOMA; PROTEIN LOSING GASTROENTEROPATHY; SEROLOGY; THORACOCENTESIS;

ADULT; AZURE STAINS; CHYLOTHORAX; CHYLOUS ASCITES; FEMALE; HEPATITIS C; HERPESVIRUS 8, HUMAN; HUMANS; LYMPHOMA, B-CELL; PLEURAL EFFUSION, MALIGNANT; PROTEIN-LOSING ENTEROPATHIES; RECURRENCE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 1842844987     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.236     Document Type: Article

References (38)

1. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88: 645-656, 1996.
2. Banks PM, Warnke RA. Primary effusion lymphoma. in: Tumors of Haematopietic and Lymphoid Tissues. Jaffe ES, Harris NL, Stein H, Vardiman JW. Eds. IARC Press, 2001: 179-180.
3. Ohshima K, Ishiguro M, Yamasaki S, et al. Chromosomal and comparative genomic analyses of HHV-8-negative primary effusion lymphoma in five HIV-negative Japanese patients. Leuk Lymphoma 43: 595-601, 2002.
4. Browse NL, Wilson NM, Russo F, al-Hassan H, Allen DR. Aetiology and treatment of chylous ascites. Br J Surg 79: 1145-1150, 1992.
5. Kristoffersson U, Heim S, Mandahl N, et al. Prognostic implication of cytogenetic findings in 106 patients with non-Hodgkin lymphoma. Cancer Genet Cytogenet 25: 55-64, 1987.
6. Xaubet A, Diumenjo MC, Marin A, et al. Characteristics and prognostic value of pleural effusions in non-Hodgkin's lymphomas. Eur J Respir Dis 66: 135-140, 1985.
7. Said JW, Tasaka T, Takeuchi S, et al. Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women. Blood 88: 3124-3128, 1996.
8. Polskj JM, Evans HL, Grosso LE, Popovic WJ, Taylor L, Dunphy CH. CD7 and CD56-positive primary effusion lymphoma in a human immunodeficiency virus-negative host. Leuk Lymphoma 39: 633-639, 2000.
9. Klepfish A, Sarid R, Shtalrid M, Shvidel L, Berrebi A, Schattner A. Primary effusion lymphoma (PEL) in HIV-negative patients - a distinct clinical entity. Leuk Lymphoma 41: 439-443, 2001.
10. Perez CL, Rudoy S. Anti-CD20 monoclonal antibody treatment of human herpesvirus 8-associated, body cavity-based lymphoma with an unusual phenotype in a human immunodeficiency virus-negative patient. Clin Diagn Lab Immunol 8: 993-996, 2001.
11. Ichinohasama R, Miura I, Kobayashi N, et al. Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature. Am J Surg Pathol 22: 1528-1537, 1998.
12. Ascoli V, Lo Coco F, Artini M, Levrero M, Fruscalzo, A, Mecucci C. Primary effusion Burkitt's lymphoma with t (8; 22) in a patient with hepatitis C virus-related cirrhosis. Hum Pathol 28: 101-104, 1997.
13. Hara T, Nishi S, Horimoto A, Takenaka S, Ibata Y, Akamatsu H. Primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. J Gastroenterol Hepatol 16: 948-949, 2001.
14. Saiki M, Saitoh T, Inoue M, et al. Human herpesvirus-8 negative primary effusion lymphoma with complete clinical remission after removal of ascites. Rinsho Ketsueki (Jpn J Clin Hematol) 43: 548-553, 2002 (In Japanese, Abstract in English).
15. Carbone A, Gloghini A, Vaccher E, et al. Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br J Haematol 94: 533-543, 1996.
16. Hermine O, Michel M, Buzyn-Veil A, Gessain A. Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences. New Engl J Med 334: 272-273, 1996.
17. Rodriguez J, Romaguera JE, Katz RL, Said J, Cabanillas F. Primary effusion lymphoma in an HIV-negative patient with no serologic evidence of Kaposi's sarcoma virus. Leuk Lymphoma 41: 185-189, 2001.
18. Ashihara E, Shimazaki C, Hirai H, et al. Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube. Int J Hematol 74: 327-332, 2001.
19. Zignego AL, Macchia D, Monti M, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 15: 382-386, 1992.
20. Izumi T, Sasaki R, Miura Y, Okamoto H. B cell malignancy and hepatitis C virus infection. Leuk Res 20: 445, 1996.
21. Zuckerman E, Zuckerman T, Levine AM, et al. Hepatitis C infection in patients with non-Hodgkin B-cell lymphoma. Ann Intern Med 127: 423-428, 1997.
22. Vallisa D, Berte R, Rocca A, et al. Association between hepatitis virus C and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. Am J Med 106: 556-560, 1999.
23. De Vita S, Sansonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 88: 1887-1892, 1995.
24. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 88: 4638-4645, 1996.
25. Mcdonnel TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t (14; 18). Nature 349: 254-256, 1991.
26. Ray RB, Meyer K, Ray R. Suppression of apoptotic cells death by hepatitis C virus core protein. Virology 226: 176-182, 1996.
27. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 359: 554-556, 1992.
28. Waldmann TA. Protein-losing enteropathy. Gastroenterology 50: 422-443, 1966.
29. Ward M, Le Roux A, Small WP, Sircus W. Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad Med J 53: 753-757, 1977.
30. Nishiuchi M, Iida M, Saika Y, et al. Malignant lymphoma originating in the jejunum of a long-term follow-up case of protein-losing enteropathy. Intern Med 36: 556-560, 1997.
31. Kojima H, Hasegawa Y, Nakazawa M, et al. Non-Hodgkin lymphoma associated with a long history of protein losing enteropathy. Rinsho Ketsueki (Jpn J Clin Hematol) 30: 2210-2214, 1989 (In Japanese, Abstract in English).
32. Wright DH. The major complications of coeliac disease. Baillieres Clin Gastroenterol 9: 351-369, 1995.
33. Shpilberg O, Shimon I, Bujanover Y, Ben-Bassat I. Remission of malabsorption in congenital intestinal lymphangiectasia following chemotherapy for lymphoma. Leuk Lymphoma 11: 147-148, 1993.
34. Iuchi K, Ichiyama A, Akashi A, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer 60: 1771-1775, 1987.
35. Wilson KS, McKenna RW, Kroft SH, Dawson DB, Ansari Q, Schneider NR. Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities. Br J Haematol 116: 113-121, 2002.
36. Drexler HG, Uphoff CC, Gaidano G, Carbone A. Lymphoma cell lines: in vitro models for study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia 12: 1507-1517, 1998.
37. Mullaney BP, Ng VL, Herndier BG, McGrath MS, Pallavicini MG. Comparative genomic analyses of primary effusion lymphoma. Arch Pathol Lab Med 124: 824-826, 2000.
38. Komanduri KV, Luce JA, McGrath MS, Herndier BG, Ng VL. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J Acquir Immune Defic Syndr Hum Retrovirol 13: 215-226, 1996.